Basel, 31 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Elecsys® EBV panel has launched in countries accepting the CE Mark. Roche will file for approval with the FDA in the ...

Durham, NC - A relationship between Epstein-Barr virus (EBV) infection and development of systemic lupus erythematosus (SLE) has long been suspected, but since 90% of adults show signs of latent EBV, ...

Please provide your email address to receive an email when new articles are posted on . The study included 4,721 individuals with Epstein-Barr virus (EBV)-positive infection mononucleosis (IM) and ...

In a recent study published in the journal PLOS Pathogens, researchers investigated humoral and cell-mediated immune responses to Epstein-Barr virus (EBV) in multiple sclerosis (MS) patients, ...

The results of preclinical research headed by a team at Karolinska Institutet have indicated how T cells that play a role in the immune system’s reaction to the common Epstein-Barr virus (EBV) can ...

Nine in 10 people worldwide have been infected with Epstein-Barr virus (EBV). But only a small number will go on to develop serious illnesses that have been linked to the virus, such as lupus, chronic ...

Two recently published studies available on the National Institutes of Health (NIH) website indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID ...

The case of warm autoimmune hemolytic anemia (AIHA) highlights the potential for life-threatening acute hemolysis if patients do not receive timely treatment. AIHA is a rare condition characterized by ...